2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

Clyde W. Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E. Casey, Monica M. Colvin, Mark H. Drazner, Gerasimos Filippatos, Gregg C. Fonarow, Michael M. Givertz, Steven M. Hollenberg, Jo Ann Lindenfeld, Frederick A. Masoudi, Patrick E. McBride, Pamela N. Peterson, Lynne Warner Stevenson, Cheryl Westlake, Jonathan L. Halperin, Glenn N. Levine, Sana M. Al-KhatibKim K. Birtcher, Biykem Bozkurt, Ralph G. Brindis, Joaquin E. Cigarroa, Lesley H. Curtis, Lee A. Fleisher, Federico Gentile, Samuel Gidding, Mark A. Hlatky, John Ikonomidis, José Joglar, Susan J. Pressler, Duminda N. Wijeysundera

Research output: Contribution to journalArticlepeer-review

69 Scopus citations
Original languageEnglish (US)
Pages (from-to)659-669
Number of pages11
JournalJournal of Cardiac Failure
Volume22
Issue number9
DOIs
StatePublished - Sep 1 2016

Keywords

  • AHA Scientific Statements
  • angioedema
  • angiotensin receptor blockers
  • angiotensin receptor-neprilysin inhibitor
  • angiotensin-converting enzyme inhibitors
  • beta blockers
  • focused update
  • heart failure
  • ivabradine
  • natriuretic peptides

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this